Search review questions

Number of antenatal hospital admissions · pregnant women with chronic or gestational hypertension

Maternal admission to intensive care · pregnant women with chronic or gestational hypertension

Induction of labour · pregnant women with chronic or gestational hypertension

Neonatal outcomes · pregnant women with chronic or gestational hypertension

Stillbirth (death after 24 weeks inutero) · pregnant women with chronic or gestational hypertension

Live birth · improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss

Live birth · women with persistent antiphospholipid antibodies and recurrent pregnancy loss

Pre‐eclampsia · women with persistent antiphospholipid antibodies and recurrent pregnancy loss

Adverse events in the mother ‐ Bleeding · women with persistent antiphospholipid antibodies and recurrent pregnancy loss

Adverse events in the mother ‐ Heparin‐induced thrombocytopenia · women with persistent antiphospholipid antibodies and recurrent pregnancy loss

Adverse events in the mother ‐ Allergic reactions · women with persistent antiphospholipid antibodies and recurrent pregnancy loss

Venous thromboembolism · women with persistent antiphospholipid antibodies and recurrent pregnancy loss

Arterial thromboembolism · women with persistent antiphospholipid antibodies and recurrent pregnancy loss

Pregnancy loss · women with persistent antiphospholipid antibodies and recurrent pregnancy loss

Preterm delivery of a live infant · women with persistent antiphospholipid antibodies and recurrent pregnancy loss

Intrauterine growth restriction · women with persistent antiphospholipid antibodies and recurrent pregnancy loss

Pre‐eclampsia · improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss

Adverse events in the child ‐ Congenital malformations · women with persistent antiphospholipid antibodies and recurrent pregnancy loss

Adverse events in the mother ‐ Bleeding · improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss

Venous thromboembolism · improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss

Arterial thromboembolism · improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss

Pregnancy loss · improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss

Preterm delivery of a live infant · improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss

Intrauterine growth restriction · improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss

Adverse events in the child ‐ Congenital malformations · improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss

Serious neonatal morbidity (Reported in Miller 2014 as 'composite adverse outcome', which included the following neonatal morbidities: respiratory distress syndrome, necrotising enterocolitis, intraventricular haemorrhage, retinopathy of prematuri...

Perinatal loss: all ‐ including miscarriages and stillbirth (Note: data not available for neonatal death)

Baby discharged home healthy

Neonatal death before discharge

Stillbirth: intrauterine death at 24 or more weeks

Preterm birth < 34 completed weeks of pregnancy

Hypertensive disorders (including pre‐eclampsia, pregnancy‐induced hypertension, eclampsia) · pregnant women diagnosed with gestational diabetes

Composite serious neonatal outcomes (variously defined by trials, e.g. infant death, shoulder dystocia, bone fracture, or nerve palsy · pregnant women diagnosed with gestational diabetes

Neurosensory disability · pregnant women diagnosed with gestational diabetes

Neonatal hypoglycaemia requiring treatment (variously defined) · pregnant women diagnosed with gestational diabetes

Adiposity (neonatal/child/child as an adult) · pregnant women diagnosed with gestational diabetes

Diabetes(type1 or type2) or impaired glucose tolerance (child/adult) · pregnant women diagnosed with gestational diabetes

Subsequent development of type 2 diabetes · pregnant women diagnosed with gestational diabetes

Mode of birth (caesarean) · pregnant women diagnosed with gestational diabetes

Induction of labour · pregnant women diagnosed with gestational diabetes

Perineal trauma · pregnant women diagnosed with gestational diabetes

Postnatal weight retention or return to pre‐pregnancy weight · pregnant women diagnosed with gestational diabetes

Postnatal depression · pregnant women diagnosed with gestational diabetes

Perinatal (fetal and neonatal) mortality · pregnant women diagnosed with gestational diabetes

Large‐for‐gestational age > 90 centile · pregnant women diagnosed with gestational diabetes

Pain intensity · women with persistent or prolonged retention of placenta

Adverse events · women with persistent or prolonged retention of placenta

Postpartum haemorrhage (blood loss ≥ 500 mL) · women with persistent or prolonged retention of placenta

Requirement of additional analgesia or general anaesthesia · women with persistent or prolonged retention of placenta

Serious maternal morbidity · women with persistent or prolonged retention of placenta